ArticleStem cell reviews and reports2025
Dual Role of DLK1 in GnRH Neuron Ontogeny.
Article in Stem cell reviews and reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mutations in Delta Like Non-Canonical Notch Ligand 1 (DLK1), a paternally expressed imprinted gene, underlie central precocious puberty (CPP), yet the mechanism remains unclear. To test the hypothesis that DLK1 plays a role in gonadotropin releasing hormone (GnRH) neuron ontogeny, 75 base pairs were deleted in both alleles of DLK1 exon 3 with CRISPR-Cas9 in human pluripotent stem cells (hPSCs). This line, exhibiting More than 80% loss of DLK1 protein, was differentiated into GnRH neurons by dual SMAD inhibition (dSMADi), FGF8 treatment and Notch inhibition, as previously described, however, it did not exhibit accelerated GNRH1 expression. Activation of (WT) DLK1 with CRISPRa during dSMADi suppressed the formation of anterior neuronal precursors, and almost completely inhibited GnRH neuron fate. Instead, it induced the expression of Wnt pathway genes, markers of proliferating and non-proliferating neuronal progenitors, and dorsal spinal cord interneurons. Activation of DLK1 expression, during the FGF8 phase, significantly increased GNRH1 expression and secretion of GnRH decapeptide. In conclusion, significant loss of DLK1 protein did not accelerate GNRH1 expression, suggesting that CPP caused by paternally inherited loss-of-function mutations is due to mechanisms acting up- or downstream of GnRH neurons. Conversely, timing of DLK1 activation emerged as an important factor in determining GnRH neuron fate, with early expression disrupting GnRH lineage commitment and later activation enhancing GNRH1 expression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.